Amylyx’s amyotrophic lateral sclerosis (ALS) drug, marketed as Relyvrio, has been approved by the FDA for the treatment of ALS in adults at a cost of $158,000 per year.
A new report by The J.D. Power U.S. Telehealth Satisfaction Study found that LiveHealth Online ranks first as a direct-to-consumer telehealth provider.
Abiding by their pledge to contribute to society, Tencent Holdings has introduced a new AI-based hearing device that will provide better speech intelligibility and sound precision.
Amylyx’s amyotrophic lateral sclerosis (ALS) drug, marketed as Relyvrio, has been approved by the FDA for the treatment of ALS in adults at a cost of $158,000 per year.
A new report by The J.D. Power U.S. Telehealth Satisfaction Study found that LiveHealth Online ranks first as a direct-to-consumer telehealth provider.
Abiding by their pledge to contribute to society, Tencent Holdings has introduced a new AI-based hearing device that will provide better speech intelligibility and sound precision.
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.